Additional payment obligation
Information for the Manufacturers, for the Marketing Authorisation Holders and for the Wholesalers
According to the Chapter V. of Act XCVIII of 2006. On the general rules of safe
and economic medicine and medical device provision and the distribution of medicinal
products (Furthermore: Act) there is a payment obligation. Article 40/A of the
Act
states that the responsible body for the Health Insurance Fund’s management (National
Health Insurance Fund Administration, furthermore OEP) has to provide necessary
information about the turnover and the reimbursement for the fulfilment of the
self-assessment payment obligations. OEP aims to determine transparent and unambiguous
payment obligations, so It publishes extra information on its official homepage
to help the involved companies. The published turnover and reimbursement data
are coming from the OEP’s informatics database, beyond that all provided data
are derived from the database therefore informative. The different calculations
are based on the OEP’s law interpretation. During the control of the national
tax authority (NAV) the stated data can differ from OEP’s calculation. OEP provides
this information to help the stakeholders complying with the Act.
The information about the additional payment obligation and the statements can be found here: